The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...